IL33 and rheumatoid arthritis: We hypothesize that BM ILC2s are an essential factor for RA disease initiation, and subsequent IL-33-induced ILC2s production is regulated through a negative feedback loop, leading to the peripheral eosinophilia, including rEOS accumulation in joint.